Bentonite clinical trials
How each study uses Bentonite is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
8 studies that test it; most in 2006 (2)
| Year | Studies |
|---|---|
| 2005 | 1 |
| 2006 | 2 |
| 2013 | 1 |
| 2014 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2020 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 4 · Other 4
Ipsen (4) · Ain Shams Maternity Hospital (1) · Luca Ronfani (1) · Tianjin Medical University Cancer Institute and Hospital (1) · Centre Francois Baclesse (1)
Often tested with
Tested in the same studies.
Loperamide (2) · Lactobacillus bulgaricus/Bifidobacterium longum/Streptococcus thermophilus-based Probiotic Supplement (1)
Studies
Open first, then newest update. How each study uses Bentonite is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 8
- Evaluation of Smectite Effect As A Food Thickener On Gastroesophageal Reflux Disease In Neonates Using Combined Esophageal Multichannel Intraluminal ImpedanceCompletedPhase 4Ain Shams Maternity HospitalNCT04788485Written as Diosmectite
- Prevention and Treatment of Pyrrolitinib-associated DiarrheaStatus unknownPhase 2/3Tianjin Medical University Cancer Institute and HospitalNCT04736186Written as Loperamide and montmorillonite powder
- Study to Evaluate Smecta® vs Placebo on the Time to Recovery Following an Acute Diarrhoea Episode in AdultsCompletedPhase 4IpsenNCT00276328Written as Diosmectite (Smecta®)
- Effectiveness of Smecta in Combination With Oral Rehydration in the Treatment of Acute Watery Diarrhoea in Infants and ChildrenCompletedPhase 3IpsenNCT00352989Written as Smecta (Diosmectite), duration of treatment - 7 days
- Effectiveness of Smecta in the Treatment of Acute Diarrhoea in ChildrenCompletedPhase 3IpsenNCT00352716Written as Smecta (Diosmectite), duration of treatment - 7 days
- Chronic Administration of Diosmectite (SMECTA®) in Subjects With Chronic DiarrhoeaCompletedPhase 1IpsenNCT03045926Written as Diosmectite (Smecta®)
- Protein Sorbent Properties of Montmorillonite in Vitro and in Vivo ModelsCompletedNot applicableLuca RonfaniNCT02124330Written as montmorillonite 5 g
- Evaluation of the Efficacy of Low-dose Acetylsalicylic Acid on Diarrhea Induced by Anti-cancer Targeted Therapies.WithdrawnPhase 2Centre Francois BaclesseNCT02323516Written as diosmectite + loperamide
Codes
What other systems call Bentonite · ClinicalTrials.gg INT007053
- MeSH (NLM) D001546BentoniteConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) A585MN1H2LMONTMORILLONITEConfirmed FDA, NLM
- RxNorm 1425919One source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D001546 | Bentonite | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | A585MN1H2L | MONTMORILLONITE | Confirmed FDA, NLM |
| RxNorm | 1425919 | — | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.